HRT Patch vs Pill vs Gel: Which Delivery Method Is Safest?

All three deliver estrogen (and sometimes other hormones), but *how* the hormone enters your body is the key difference — and it changes the safety profile more than most people expect.

An oral pill is swallowed, so the estrogen is absorbed through your gut and travels first to your liver before reaching the rest of your body. This is called the first-pass effect. The liver processes the estrogen and, in doing so, ramps up production of several clotting factors. That's the root of the higher clot risk seen with pills.

A patch sticks to your skin and releases estrogen slowly into your bloodstream, usually changed once or twice a week. A gel (or spray) is rubbed onto the skin daily. Both the patch and gel are transdermal — "through the skin" — which means the estrogen enters the bloodstream directly and largely skips that first liver pass. Because the liver isn't flooded with estrogen, clotting factors aren't stimulated the same way.

So the headline is simple: pills go through the liver first; patches and gels don't. That single difference drives most of the safety comparison that follows. All three can relieve hot flashes, night sweats, and other symptoms effectively — this isn't about which works, but about which fits your risk profile.

Transdermal estrogen — the patch or gel — has the lowest clot risk, and the evidence here is fairly consistent. Pooled observational studies put the relative risk of venous thromboembolism (VTE, a clot in a vein such as a deep-vein thrombosis) at about 1.9 for oral estrogen but roughly 1.0 for transdermal — meaning transdermal use showed essentially no increase over baseline.

The mechanism explains why. Oral estrogen increases thrombin generation and creates a state of activated protein C resistance — technical terms for "blood that clots more readily." Transdermal estrogen has minimal effect on these clotting measures because it bypasses the liver's first-pass processing.

Stroke risk follows a similar pattern: it's higher with oral estrogen but is unlikely to rise meaningfully with transdermal delivery. This is why modern guidelines have shifted. NICE 2024 guidance specifically recommends transdermal HRT for women at higher VTE risk, including those with a BMI over 30. The North American Menopause Society has similarly noted transdermal advantages.

None of this means pills are dangerous for everyone — for a healthy woman under 60 with no clot risk factors, the absolute risk remains low. But if you have any personal or family history of clots, transdermal is usually the safer starting point. This safety conversation connects closely to *when* you start; see our explainer on [the timing hypothesis for starting HRT](/blog/when-to-start-hrt-the-timing-hypothesis-explained).

Despite the clot data, pills remain a reasonable option for many women — and for some, the best one. If you have no personal or family history of blood clots, stroke, or cardiovascular disease, are within about 10 years of your last period, and are under 60, your absolute clot risk on oral estrogen is still low.

Pills have real advantages. They're simple: one tablet, no skin irritation, no remembering to reapply gel or worrying a patch will peel off in the shower or at the pool. Some women find skin adhesives irritating or find gels messy or inconvenient to time around dressing. For these women, a pill's convenience genuinely improves the odds they'll stay consistent — and consistency matters more than a small theoretical risk difference.

There's also a possible upside: oral estrogen's liver effect can raise HDL ("good") cholesterol somewhat, though this doesn't clearly translate to better heart outcomes and is offset by the clot concern.

The honest summary is that route choice is individual. A woman with clot risk factors or a high BMI should lean transdermal; a low-risk woman who values simplicity may reasonably choose a pill. What matters is having the conversation with your prescriber rather than assuming one route fits all. The type of estrogen molecule matters too — our guide to [bioidentical versus synthetic HRT](/blog/bioidentical-vs-synthetic-hrt-whats-the-difference) covers that separate but related decision.

If you've decided transdermal is right for you, the next question is patch versus gel, and here it's largely about lifestyle and preference rather than safety — both share the low-clot-risk advantage.

A patch delivers a steady dose and only needs changing once or twice a week, which many women love for its "set it and forget it" simplicity. The trade-offs: some skin types react to the adhesive with redness or itching, patches can loosen with heat, sweat, or swimming, and the sticky residue can annoy. Rotating placement sites helps reduce irritation.

A gel (or spray) is applied to the skin daily, usually on the arm or thigh. It gives more dosing flexibility — your prescriber can fine-tune the amount — and there's no adhesive to irritate skin. The downsides: you have to remember it every day, let it dry before dressing, and avoid transferring it to others through skin contact until absorbed.

Absorption can vary slightly person to person with both forms, so your provider may check symptoms and occasionally levels to confirm you're getting an effective dose. Many women try one, then switch if it doesn't fit their routine — that's completely normal. The "best" transdermal option is simply the one you'll use reliably.

This is critical: if you still have your uterus, estrogen alone — by any route — is not enough. Unopposed estrogen thickens the endometrium (the uterine lining) and raises the risk of endometrial cancer over time. To protect against this, estrogen must be paired with progesterone (or a progestogen).

This applies whether your estrogen comes from a pill, patch, or gel. Some products combine both hormones in one patch or pill for convenience; other times progesterone is taken separately, often as a nightly capsule that can also help with sleep. If you've had a hysterectomy and no longer have a uterus, you typically don't need progesterone and can take estrogen on its own.

Progesterone does more than protect the lining — it has its own effects on sleep, mood, and calm, and the type and timing matter. We cover this fully in our guide to [progesterone in menopause and why it matters](/blog/progesterone-in-menopause-what-it-does-and-why-it-matters).

One more note: for purely local symptoms like vaginal dryness or recurrent UTIs, low-dose vaginal estrogen is a separate, very-low-risk option that works differently from whole-body HRT — see our piece on [vaginal estrogen for dryness and UTIs](/blog/vaginal-estrogen-local-hrt-for-dryness-and-utis). Your ideal regimen may combine approaches, which is exactly the kind of personalized plan worth mapping out with a knowledgeable provider.